Jiabao

Beijing, China Founded: 2011 • Age: 15 yrs
Next-generation sequencing services for assisted reproduction are integrated.
Request Access

About Jiabao

Jiabao is a company based in Beijing (China) founded in 2011 by Feng Tao.. Jiabao has raised $14.35 million across 3 funding rounds from investors including Apricot Capital, ShenZhen GTJA Investment Group and Shanghai Life Insurance. Jiabao operates in a competitive market with competitors including Celmatix, Metabolomic Diagnostics, Ovation Fertility, NX Prenatal and LIA Diagnostics, among others.

  • Headquarter Beijing, China
  • Founders Feng Tao
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $14.35 M (USD)

    in 3 rounds

  • Latest Funding Round
    $14.35 M (USD), Series B

    Aug 10, 2020

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Jiabao

Jiabao has successfully raised a total of $14.35M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $14.35 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series B — $14.3M
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2020 Amount Series B - Jiabao Valuation Apricot Capital
Jun, 2018 Amount Series B - Jiabao Valuation ShenZhen GTJA Investment Group
Jun, 2017 Amount Series B - Jiabao Valuation Shanghai Life Insurance
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Jiabao

Jiabao has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Apricot Capital, ShenZhen GTJA Investment Group and Shanghai Life Insurance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Jiabao

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Jiabao

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jiabao Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Jiabao

Jiabao operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celmatix, Metabolomic Diagnostics, Ovation Fertility, NX Prenatal and LIA Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Fertility decisions are optimized using data analytics and genomics.
domain founded_year HQ Location
Diagnostics and prognostics for maternal health are developed using metabolomics.
domain founded_year HQ Location
Genetic diagnostics for fertility centers are offered through molecular testing.
domain founded_year HQ Location
Early warning blood tests for pregnancy complications are provided.
domain founded_year HQ Location
Disposable paper pregnancy test kits
domain founded_year HQ Location
Clinical-grade diagnostic tests for home use are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Jiabao

Frequently Asked Questions about Jiabao

When was Jiabao founded?

Jiabao was founded in 2011 and raised its 1st funding round 6 years after it was founded.

Where is Jiabao located?

Jiabao is headquartered in Beijing, China.

Who is the current CEO of Jiabao?

Feng Tao is the current CEO of Jiabao. They have also founded this company.

Is Jiabao a funded company?

Jiabao is a funded company, having raised a total of $14.35M across 3 funding rounds to date.

What does Jiabao do?

Beijing Jiabao Renhe Medical Technology was founded in 2011 and is based in Beijing, China. Operations focus on the assisted reproduction sector, where genetic testing technologies for pre-pregnancy, pre-implantation screening and diagnosis, prenatal, and neonatal applications are provided. Equipment, consumables, diagnostics, and reagents are supplied, along with bioinformatics analysis platforms and sequencing systems.

Who are the top competitors of Jiabao?

Jiabao's top competitors include Celmatix, NX Prenatal and Metabolomic Diagnostics.

Who are Jiabao's investors?

Jiabao has 3 investors. Key investors include Apricot Capital, ShenZhen GTJA Investment Group, and Shanghai Life Insurance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available